Elaine S. Wai

950 West 10th. Avenue
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Treatment Outcomes of Low-grade Lymphoma of the Orbit.

Treatment Outcomes of Low-grade Lymphoma of the Orbit.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: March 04, 2021

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab.

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab.

Journal: Translational lung cancer research

Published: February 11, 2021

Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort.

Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: December 08, 2020

Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab.

Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab.

Journal: Current oncology (Toronto, Ont.)

Published: June 04, 2020

Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab.

Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab.

Journal: Journal of geriatric oncology

Published: August 26, 2019

Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice.

Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 11, 2019

Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.

Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.

Journal: International journal of radiation oncology, biology, physics

Published: July 30, 2018

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.

Journal: Clinical lung cancer

Published: June 17, 2018

Programmatic Comparison and Dissemination of an Audit of Single-fraction Radiation Therapy Prescribing Practices for Bone Metastases is Associated with a Meaningful and Lasting Change in Practice on a Population Level.

Programmatic Comparison and Dissemination of an Audit of Single-fraction Radiation Therapy Prescribing Practices for Bone Metastases is Associated with a Meaningful and Lasting Change in Practice on a Population Level.

Journal: International journal of radiation oncology, biology, physics

Published: April 20, 2018

Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case Series.

Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case Series.

Journal: Cureus

Published: January 10, 2018

Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.

Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 08, 2017

Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.

Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.

Journal: Cureus

Published: May 04, 2017

Showing 1-12 of 31

Last Updated: 09/26/2026